FI920646A0 - Farmaceutiska preparat. - Google Patents

Farmaceutiska preparat.

Info

Publication number
FI920646A0
FI920646A0 FI920646A FI920646A FI920646A0 FI 920646 A0 FI920646 A0 FI 920646A0 FI 920646 A FI920646 A FI 920646A FI 920646 A FI920646 A FI 920646A FI 920646 A0 FI920646 A0 FI 920646A0
Authority
FI
Finland
Prior art keywords
fat
soluble
gelatin capsules
hard gelatin
optionally
Prior art date
Application number
FI920646A
Other languages
English (en)
Inventor
Michael John Story
Original Assignee
Cortecs Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB898918809A external-priority patent/GB8918809D0/en
Application filed by Cortecs Ltd filed Critical Cortecs Ltd
Publication of FI920646A0 publication Critical patent/FI920646A0/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Nutrition Science (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • General Preparation And Processing Of Foods (AREA)
FI920646A 1989-08-17 1992-02-14 Farmaceutiska preparat. FI920646A0 (fi)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB898918809A GB8918809D0 (en) 1989-08-17 1989-08-17 Pharmaceutical formulations
PCT/GB1990/001299 WO1991002520A1 (en) 1989-08-17 1990-08-17 Pharmaceutical formulations
US08/430,500 US5738871A (en) 1989-08-17 1995-04-28 Pharmaceutical formulations

Publications (1)

Publication Number Publication Date
FI920646A0 true FI920646A0 (fi) 1992-02-14

Family

ID=26295779

Family Applications (1)

Application Number Title Priority Date Filing Date
FI920646A FI920646A0 (fi) 1989-08-17 1992-02-14 Farmaceutiska preparat.

Country Status (13)

Country Link
US (1) US5738871A (fi)
EP (1) EP0487575B1 (fi)
JP (1) JPH04507418A (fi)
AT (1) ATE113471T1 (fi)
AU (1) AU633959B2 (fi)
CA (1) CA2063791C (fi)
DE (1) DE69013923T2 (fi)
DK (1) DK0487575T3 (fi)
ES (1) ES2062543T3 (fi)
FI (1) FI920646A0 (fi)
HK (1) HK85196A (fi)
NO (1) NO302333B1 (fi)
WO (1) WO1991002520A1 (fi)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2281697A (en) * 1993-09-14 1995-03-15 Euro Celtique Sa Laxative compositions in capsules
DE69426408T2 (de) 1993-09-28 2001-07-12 Novartis Ag, Basel Herstellung von Weichgelatinekapseln
GB9325445D0 (en) 1993-12-13 1994-02-16 Cortecs Ltd Pharmaceutical formulations
US5567592A (en) * 1994-02-02 1996-10-22 Regents Of The University Of California Screening method for the identification of bioenhancers through the inhibition of P-glycoprotein transport in the gut of a mammal
GB9405304D0 (en) * 1994-03-16 1994-04-27 Scherer Ltd R P Delivery systems for hydrophobic drugs
WO1997019601A1 (en) * 1995-11-24 1997-06-05 Loders Croklaan B.V. Composition based on fish oil
US6056971A (en) * 1996-07-24 2000-05-02 Biosytes Usa, Inc. Method for enhancing dissolution properties of relatively insoluble dietary supplements and product incorporating same
GB9705813D0 (en) * 1997-03-20 1997-05-07 Smithkline Beecham Plc Novel compositions
AUPP022297A0 (en) 1997-11-06 1997-11-27 R.P. Scherer Holdings Pty Ltd Vitamin coating
TW367247B (en) * 1998-02-03 1999-08-21 Otsuka Pharma Co Ltd Storage container for Vitamin D solution and transfusion container
US6652880B1 (en) 1999-04-01 2003-11-25 R.P. Scherer Technologies, Inc. Oral pharmaceutical compositions containing long-chain triglycerides and liphophilic surfactants
US6346231B1 (en) * 1999-10-06 2002-02-12 Joar Opheim Flavored gelatin capsule and method of manufacture
US6365181B1 (en) 2000-04-20 2002-04-02 Gattefosse Corporation Thixatropic gelatin carrier composition
GB0101198D0 (en) 2001-01-17 2001-02-28 Scherer Technologies Inc R P Ingestible compositions containing an odoriferous oil
AUPR510001A0 (en) * 2001-05-18 2001-06-14 Jupitar Pty Ltd Formulation and method
WO2003086267A2 (en) * 2002-04-10 2003-10-23 Miller Fred H Multi-phase, multi-compartment capsular system
US7670612B2 (en) * 2002-04-10 2010-03-02 Innercap Technologies, Inc. Multi-phase, multi-compartment capsular delivery apparatus and methods for using same
EP1589930A2 (en) * 2003-01-08 2005-11-02 Flacco-Nesselroad Family Trust Combination therapy for anticoagulation
JP2005075804A (ja) * 2003-09-03 2005-03-24 Toyo Capsule Kk メナテトレノン含有医薬組成物
US20080234343A1 (en) * 2004-03-24 2008-09-25 Takeda Pharmaceutical Company Preparation with Elevated Content
US20050232981A1 (en) 2004-04-15 2005-10-20 Ben-Sasson Shmuel A Compositions capable of facilitating penetration across a biological barrier
EP1786274A1 (en) * 2004-08-31 2007-05-23 Akzo Nobel N.V. Method for pigment solubilisation, a pigment composition and its use
CA2659206A1 (en) * 2006-06-27 2008-01-03 Akzo Nobel N.V. Formulations comprising a vitamin and the use thereof to make fortified feed and personal care formulations
CA2702577A1 (en) 2007-10-15 2009-04-23 Jbs United, Inc. Method for increasing performance of offspring
JP6063615B2 (ja) * 2008-04-29 2017-01-18 株式会社日健総本社 眼の医学的症状の治療用組成物
JP5443470B2 (ja) 2008-04-29 2014-03-19 株式会社日健総本社 眼障害の治療方法
BRPI0918652B1 (pt) 2008-09-17 2021-10-19 Chiasma, Inc. Composição farmacêutica compreendendo um meio hidrofóbico e uma forma sólida que compreende polipeptídeo e sal de ácido graxo de cadeia média, processo de produção da mesma e forma de dosagem oral
WO2010103402A1 (en) * 2009-03-09 2010-09-16 Pronova Biopharma Norge As Compositions comprising a fatty acid oil mixture comprising epa and dha in free acid form and a surfactant, and methods and uses thereof
US8197871B2 (en) * 2009-05-13 2012-06-12 L Europa Gary A Composition for headache treatment
US9370493B2 (en) * 2009-10-23 2016-06-21 Pronova Biopharma Norge As Coated capsules and tablets of a fatty acid oil mixture
US10610528B2 (en) * 2009-12-08 2020-04-07 Intelgenx Corp. Solid oral film dosage forms and methods for making same
US8722131B2 (en) 2010-09-07 2014-05-13 Dsm Nutritional Products Ag Comestible emulsions
US8951514B2 (en) 2011-02-16 2015-02-10 Pivotal Therapeutics Inc. Statin and omega 3 fatty acids for reduction of apolipoprotein-B levels
US9119826B2 (en) 2011-02-16 2015-09-01 Pivotal Therapeutics, Inc. Omega 3 fatty acid for use as a prescription medical food and omega 3 fatty acid diagniostic assay for the dietary management of cardiovascular patients with cardiovascular disease (CVD) who are deficient in blood EPA and DHA levels
US8952000B2 (en) 2011-02-16 2015-02-10 Pivotal Therapeutics Inc. Cholesterol absorption inhibitor and omega 3 fatty acids for the reduction of cholesterol and for the prevention or reduction of cardiovascular, cardiac and vascular events
US8715648B2 (en) 2011-02-16 2014-05-06 Pivotal Therapeutics Inc. Method for treating obesity with anti-obesity formulations and omega 3 fatty acids for the reduction of body weight in cardiovascular disease patients (CVD) and diabetics
MX2016016612A (es) 2014-06-17 2017-03-20 Merck Sharp & Dohme Formulaciones estables de undecanoato de testosterona.
US10238709B2 (en) 2015-02-03 2019-03-26 Chiasma, Inc. Method of treating diseases
KR102678365B1 (ko) * 2018-03-20 2024-06-26 재단법인 경기도경제과학진흥원 콜레칼시페롤의 가용화 조성물 및 그 제조방법
US11141457B1 (en) 2020-12-28 2021-10-12 Amryt Endo, Inc. Oral octreotide therapy and contraceptive methods
DE102021003906B4 (de) 2021-07-30 2023-03-30 Mirco Bienhaus Verfahren und Vorrichtungen zur Herstellung fester oder halbfester Arzneiformen mit einem mehrschichtigen Aufbau

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5665820A (en) * 1979-11-02 1981-06-03 Eisai Co Ltd Hard capsule with high content of tocopherol nicotinate
DE3237814A1 (de) * 1982-10-12 1984-04-12 Warner-Lambert Co., 07950 Morris Plains, N.J. Wasserfreie emulsionen und verwendung derselben
AU561367B2 (en) * 1983-05-02 1987-05-07 Scherer, R.P. Pty. Ltd. Vitamin composition with enhanced bioavailability
US4572915A (en) * 1984-05-01 1986-02-25 Bioglan Laboratories Clear micellized solutions of fat soluble essential nutrients
JPS61221131A (ja) * 1985-03-28 1986-10-01 Eisai Co Ltd 吸収促進したユビデカレノン含有組成物
US4795642A (en) * 1986-05-01 1989-01-03 Pharmacaps, Inc. Gelatin-encapsulated controlled-release composition
GB8630273D0 (en) * 1986-12-18 1987-01-28 Til Medical Ltd Pharmaceutical delivery systems
US4816259A (en) * 1987-02-12 1989-03-28 Chase Chemical Company, L.P. Process for coating gelatin capsules
NZ224497A (en) * 1987-05-18 1990-04-26 Janssen Pharmaceutica Nv Pharmaceutical composition comprising flunarizine
JPH01233218A (ja) * 1988-03-15 1989-09-19 Daikyo Yakuhin Kogyo Kk ビタミン組成物
US5188688A (en) * 1990-07-20 1993-02-23 Minnesota Mining And Manufacturing Company Method of sealing a gelatin capsule
US5455045A (en) * 1993-05-13 1995-10-03 Syntex (U.S.A.) Inc. High dose formulations

Also Published As

Publication number Publication date
WO1991002520A1 (en) 1991-03-07
EP0487575B1 (en) 1994-11-02
ES2062543T3 (es) 1994-12-16
NO302333B1 (no) 1998-02-23
AU6161990A (en) 1991-04-03
NO920604D0 (no) 1992-02-14
CA2063791A1 (en) 1991-02-18
HK85196A (en) 1996-05-24
DE69013923T2 (de) 1995-03-16
DK0487575T3 (da) 1994-11-28
EP0487575A1 (en) 1992-06-03
AU633959B2 (en) 1993-02-11
JPH04507418A (ja) 1992-12-24
NO920604L (no) 1992-02-14
CA2063791C (en) 2000-12-19
DE69013923D1 (de) 1994-12-08
US5738871A (en) 1998-04-14
ATE113471T1 (de) 1994-11-15

Similar Documents

Publication Publication Date Title
FI920646A0 (fi) Farmaceutiska preparat.
EP0165352A3 (en) Clear micellized solutions of fat soluble essential nutrients
AR004483A1 (es) Compuestos para uso en terapia que comprenden un residuo de 1,3-propano diol como agente enlazante entre el residuo de ácido graso y un residuo bioactivo, usos de dichos compuestos y medicamentos , alimentos y formulaciones para el cuidado o tratamiento de la piel que comprenden a dichos compuestos
ATE236627T1 (de) Pharmazeutische zubereitung enhaltend eicosapentaensäure und/oder stearidonsäure
DK1341527T3 (da) Farmaceutisk præparat omfattende et aktivstof dispergeret på en matrix
SV2004001556A (es) Preparaciones acidas de insulina con establidad mejorada
ES2052645T3 (es) Acidos poliinsaturados con accion vasocinetica y formulaciones farmaceuticas y cosmeticas que los contienen.
CO4970836A1 (es) Formulaciones inyectables de larga accion que contienen aceite de castor hidrogenado
ES534598A0 (es) Un procedimiento para preparar una solucion acuosa que contiene una sustancia farmaceutica soluble en lipidos
ES2191862T3 (es) Composicion liquida que comprende un inhibidor de la vih proteasa y un acido graso de c12-c18.
MY104412A (en) Acne treatment.
NO863935L (no) Fremgangsmaate for fremstilling av terapeutiske preparater inneholdende 2-(2-fluor-4-bifenylyl)propionsyre.
YU17899A (sh) Farmaceutske mikrosfere valproinske kiseline za oralnu upotrebu
DK206387A (da) Anvendelse af glucofurol til flydende-goeren af laegemiddelpraeparater til fyldning i bloede gelatinkapsler
ES2051827T3 (es) Una composicion farmaceutica que contiene aceite de ricino polietoxilado.
RU98115892A (ru) Фармацевтическая композиция, содержащая циклоспорин, способ получения мягких желатиновых капсул, способ лечения
NO891220D0 (no) Middel som inneholder salicylsyre for behandling av lepidose.
AR016629A1 (es) Una solucion que comprende un azaesteroide farmaceuticamente activo y un ester de acido graso de glicerol o propilen glicol, composiciones farmaceuticasque comprenden la solucion y capsulas de gelatina rellenas con la composicion farmaceutica.
CO4970832A1 (es) Nuevas formulaciones y procesos para su fabricacion
JPS5764609A (en) Cyclophosphamide composition for rectal administration
GB1133845A (en) Pharmaceutical compositions comprising dextran and cellulose ethers
ES2168351T3 (es) Preparaciones farmaceuticas que contienen nifedipina y procedimiento para su preparacion.
IT1213033B (it) Esteri di n-alchil-nortropine eloro derivati ammonioquaternari aventi attivita'anti-broncospastica, procedimento per la loro preparazione e composizioni farmaceutiche che licontengono.
TH14737A (th) สารผสมทางเภสัชศาสตร์ที่คงตัวของอนุพันธ์ฟิวแมจิลลอล